Home/Filings/4/0001595585-20-000064
4//SEC Filing

Otto Dawn Parsell 4

Accession 0001595585-20-000064

CIK 0001595585other

Filed

May 6, 8:00 PM ET

Accepted

May 7, 5:33 PM ET

Size

14.4 KB

Accession

0001595585-20-000064

Insider Transaction Report

Form 4
Period: 2020-05-05
Otto Dawn Parsell
Sr VP, Clinical Development
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-05-057985,020 total
    Exercise: $1.68Exp: 2026-11-02Common Stock (798 underlying)
  • Exercise/Conversion

    Common Stock

    2020-05-05$1.68/sh+798$1,3411,053 total
  • Sale

    Common Stock

    2020-05-05$30.05/sh798$23,980255 total
  • Exercise/Conversion

    Common Stock

    2020-05-05$2.39/sh+452$1,080707 total
  • Sale

    Common Stock

    2020-05-05$30.31/sh452$13,700255 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-05-0545216,823 total
    Exercise: $2.39Exp: 2027-09-13Common Stock (452 underlying)
Footnotes (5)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2019.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.98 to $30.12, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) and (3) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.12 to $30.45, inclusive.
  • [F4]This option vested 25% on October 1, 2017, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.
  • [F5]This option vests 25% on September 1, 2018, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.

Issuer

Tricida, Inc.

CIK 0001595585

Entity typeother

Related Parties

1
  • filerCIK 0001748808

Filing Metadata

Form type
4
Filed
May 6, 8:00 PM ET
Accepted
May 7, 5:33 PM ET
Size
14.4 KB